- An analysis of health and dietary data for more than 8,500 pregnant women found that greater adherence to a Mediterranean-style eating plan was associated with a lower risk of preeclampsia, which is a pregnancy complication characterized by severe high blood pressure that can be serious or even fatal for both mother and child.
- The reduction in risk of preeclampsia was greatest among Black women – a population at high risk for preeclampsia.
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, April 20, 2022
(NewMediaWire) – April 20, 2022 – DALLAS – Following a Mediterranean-style diet during pregnancy was associated with a reduced risk of developing preeclampsia, and Black women appeared to have the greatest reduction of risk, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
Previous studies have found that following a Mediterranean diet, which consists primarily of vegetables, fruits, legumes, nuts, olive oil, whole grains, and fish, reduces heart disease risk in adults.
Preeclampsia, a condition during pregnancy characterized by severe high blood pressure and liver or kidney damage, is a major cause of complications and death for the mother and her unborn child. Preeclampsia also increases a woman’s risk of heart diseases, such as high blood pressure, heart attack, stroke or heart failure, by more than two times later in life. Women with preeclampsia have a higher risk of preterm delivery (giving birth before 37 weeks gestation) or low birth weight babies, and children born to mothers with preeclampsia are also at higher risk of developing high blood pressure and heart disease.
Black women are at higher risk of developing preeclampsia, yet research on potential treatments for high-risk women are limited, according to the study researchers. The researchers investigated the potential association of a Mediterranean-style diet among a large group of racially and ethnically diverse women who have a high risk of preeclampsia.
“The U.S. has the highest maternal mortality rate among developed countries, and preeclampsia contributes to it,” said Anum S. Minhas, M.D., M.H.S., chief cardiology fellow and a cardio-obstetrics and advanced imaging fellow at Johns Hopkins University in Baltimore. “Given these health hazards to both mothers and their children, it is important to identify modifiable factors to prevent the development of preeclampsia, especially among Black women who are at the highest risk of this serious pregnancy complication.”
This study included data for more than 8,500 women enrolled between 1998 and 2016 in the Boston Birth Cohort. Participants’ median age was 25 years old, and they were recruited from Boston Medical Center, which serves a predominantly urban, low-income, under-represented racial and ethnic population. Nearly half of the participants were Black women (47%), about a quarter were Hispanic women(28%) and the remaining were white women or “other” race, according to self-reported information on a postpartum questionnaire. Researchers created a Mediterranean-style diet score based on participants’ responses to food frequency interviews and questionnaires, which were conducted within three days of giving birth.
The analysis found:
- 10% of the study participants developed preeclampsia.
- Women who had any form of diabetes before pregnancy and pre-pregnancy obesity were twice as likely to develop preeclampsia compared to women without those conditions.
- The risk of preeclampsia was more than 20% lower among the women who followed a Mediterranean-style diet during pregnancy.
- Black women who had the lowest Mediterranean-style diet scores had the highest risk (72% higher) for preeclampsia compared to all other non-Black women who more closely adhered to the Mediterranean-style diet.
“We were surprised that women who more frequently ate foods in the Mediterranean-style diet were significantly less likely to develop preeclampsia, with Black women experiencing the greatest reduction in risk,” Minhas said. “This is remarkable because there are very few interventions during pregnancy that are found to produce any meaningful benefit, and medical treatments during pregnancy must be approached cautiously to ensure the benefits outweigh the potential risks to the mother and the unborn child.”
Minhas added, “Women should be encouraged to follow a healthy lifestyle, including a nutritious diet and regular exercise, at all stages in life. Eating healthy foods regularly, including vegetables, fruits and legumes, is especially important for women during pregnancy. Their health during pregnancy affects their future cardiovascular health and also impacts their baby’s health.”
The study’s limitations are related to the food frequency interviews: they were conducted once after the pregnancy, and they relied on self-reported information about which foods were eaten and how frequently they were eaten.
Co-authors are Xiumei Hong, M.D., Ph.D.; Guoying Wang, M.D., Ph.D.; Dong Keun Rhee, R.D., M.S.P.H.; Tiange Liu, M.H.S., M.B.B.S.; Mingyu Zhang, M.H.S.; Erin D. Michos, M.D., M.H.S.; Xiaobin Wang, M.D., Sc.D.; and Noel T. Mueller, Ph.D. Authors’ disclosures are listed in the manuscript.
The Boston Birth Cohort Study was supported in part by the March of Dimes; the National Institutes of Health; and the Health Resources and Services Administration of the U.S. Department of Health and Human Services. Additional funding to authors is listed in the manuscript.
Studies published in the American Heart Association’s scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173
Bridgette McNeill: 214-706-1135; email@example.com
For Public Inquiries: 1-800-AHA-USA1 (242-8721)